Tag: Atrial Fibrillation
Weight Loss Linked to Reversal of Atrial Fibrillation Progression
Increased weight loss with risk factor management associated with greater atrial fibrillation freedom
Variation in Quality of Trials for Atrial Fibrillation, Flutter
Most common trial endpoint is AF/AFL recurrence; rates of primary clinical endpoints are low
Sleep Disruption Increases Risk of Atrial Fibrillation
Higher risk seen across multiple cohorts, regardless of obstructive sleep apnea and other possible factors
Hyoscyamine Helps in A-Fib With Slow Ventricular Response
Successful response in patient with comorbidities who was a poor candidate for pacemaker placement
Nut Consumption Associated With Reduced Risk of A-Fib
Possible correlation also seen for nut consumption with reduced risk of heart failure
Lower Thromboembolic Risk With New A-Fib After CABG Versus NVAF
Thromboembolic risk lower for postoperative atrial fibrillation s/p CABG versus nonvalvular a-fib
NSAID Use Linked to A-Fib Risk in Middle-Aged Asian Population
Risk up with use of non-selective NSAIDs and combined use of selective, non-selective NSAIDs
Smartwatch May Be Able to Passively Detect Atrial Fibrillation
Coupled with deep neural network, smartwatch passively detects a-fib but less accurately than ECG
Depression, Antidepressant Use May Up Risk of A-Fib
CES-D ≥16, antidepressant use each associated with higher incidence of atrial fibrillation
Digoxin Tied to Higher Mortality in Patients With Atrial Fibrillation
Mortality risk increased with higher serum digoxin levels; results similar regardless of heart failure
